Simulations Plus

Simulations Plus Short-term Debt

Delisted·Oct 7, 2026

The Short-Term Debt of Simulations Plus (SLP) as of Nov 11, 2026 is 206,000.00 USD. In the previous year, Short-Term Debt was 475,000.00 USD — a change of -56.63% (lower).

Short-term Debt

206,000.00USD

YoY

-56.63%

Last updated:

Short-Term Debt of Simulations Plus is 2025 206,000.00 USD. Short-Term Debt of Simulations Plus was 2024 475,000.00 USD. It decreases by -56.63% lower compared to the previous year.

The Simulations Plus Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2017
247,328.00 USD
Jan 1, 2018
2.56 M USD
Jan 1, 2020
463,465.00 USD
Jan 1, 2021
382,000.00 USD
Jan 1, 2022
461,000.00 USD
Jan 1, 2023
442,000.00 USD
Jan 1, 2024
475,000.00 USD
Jan 1, 2025
206,000.00 USD
The Simulations Plus Short-term Debt history
YEARShort-term DebtYoY
206,000.00USD-56.63%
475,000.00USD+7.47%
442,000.00USD-4.12%
461,000.00USD+20.68%
382,000.00USD-17.58%
463,465.00USD-81.87%
2.56 MUSD+933.71%
247,328.00USD-84.57%
1.60 MUSD-49.90%
3.20 MUSD+164.19%
1.21 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Short-Term Debt of Simulations Plus is 206,000.00 USD in 2025.

Short-Term Debt of Simulations Plus changed from 475,000.00 USD to 206,000.00 USD, representing a -56.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Simulations Plus

All Key Metrics — Simulations Plus